Cosmos Health Inc.COSM
What Cosmos Health Inc. does.
Cosmos Health Inc. was incorporated in 2009 in Nevada and is a diversified, vertically integrated global healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of innovative medicines and repurposing drugs as well as operator of a telehealth platform.
As a global company we are harnessing our expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern pharmaceutical and nutraceutical products.
We operate in the healthcare sector and particularly in the Pharmaceutical and Nutraceutical businesses. We cover vertically several process phases within the abovementioned sectors, such as research & development, manufacturing, marketing, sales and distribution of products and services. More specifically, we operate in generic medicines, nutraceuticals, biocides, medical devices, novel oncology drugs, drug repurposing and telehealth services.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $55.4M | $56.2M | $50.3M | $53.4M | $54.4M | $65.3M |
| Net income | $820,786 | -$8.0M | -$13.8M | -$18.5M | -$16.2M | -$19.1M |
| Free cash flow | -$11.6M | -$7.7M | -$14.9M | -$16.9M | -$8.1M | -$8.5M |
More on COSM.
- Cosmos Health Inc. summary
- Cosmos Health Inc. financial statements
- Cosmos Health Inc. key metrics
- Cosmos Health Inc. health scores and style box
- Cosmos Health Inc. earnings
- Cosmos Health Inc. dividends
- Cosmos Health Inc. valuation
- Cosmos Health Inc. ownership and insiders
- Cosmos Health Inc. peers
Figures from Cosmos Health Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.